ORANGEBURG, N.Y., March 18 /PRNewswire/ -- Visionsense Corp. announces FDA 510(k) Clearance of the new VSII -- Visionsense Stereoscopic Vision System. The system is based on a miniature 3.4 mm distal ("chip-on-a-stick") stereoscopic 3D camera targeting Minimal Invasive laparoscopic and endoscopic Surgery (MIS).
Visionsense's stereoscopic 3D camera enables and enhances MIS surgical procedures that are under served by traditional 2D visualization, in markets such as: Spine, Neurosurgery, Orthopedics, Endoscopy, General Surgery, GYN, Robotics, and others.
The company has licensed the technology to various strategic marketing partners, expecting launches later this year.
About Visionsense Corp.
Visionsense exclusively licenses its technology, application or segment
specific, to strategic partners, benefiting a unique competitive advantage.
The Company develops and manufactures customized Miniature Stereoscopic 3D
cameras/sensors that enable surgeons to see "natural" Stereovision, thus
enhancing image understanding and hand-eye coordination. These re-useable
or disposable cameras are distally assembled on the tip of a flexible /
rigid scope or instrument. The technology further assists the surgeon by
providing advanced software features, such as image fusion (combining
stereovision with MRI, CT or ultrasound for real-time "see-through-tissue")
and 3D measurements.
For more information please call:
Executive Vice President
40 Ramland Road, Suite 202
Orangeburg, NY 10962
|SOURCE Visionsense Corp.|
Copyright©2008 PR Newswire.
All rights reserved